Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Feb 28 2026

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

On 6ix: 6ix.com/news/press-release-feb-28-2026-1

Release

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 28, 2026, titled "Zydus receives final approvals from USFDA for Ivermectin Tablets USP, 3 mg and Dapsone Tablets USP, 25 mg and 100 mg".

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases